Dry Eye News and Research

RSS
Dry eye is one of the most common complaints seen by eye doctors, accounting for nearly one fourth of all office visits. Caused by insufficient tear production or excessive tear evaporation, dry eye can be a mild, episodic feeling of discomfort associated with certain circumstances, such as exposure to dry, hot or windy environments; however, it can also be a chronic medical condition that, if left untreated, may lead to increased risk of infection or visual impairment.
Isotechnika Pharma develops portfolio of NICAMs with potent cyclophilin inhibition

Isotechnika Pharma develops portfolio of NICAMs with potent cyclophilin inhibition

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve

ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve

Auxano point-of-care indicator system for dry eye syndrome

Auxano point-of-care indicator system for dry eye syndrome

FDA grants Fast Track designation for MacuSight's Perceiva

FDA grants Fast Track designation for MacuSight's Perceiva

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Mimetogen Pharmaceuticals completes its equity financing

Mimetogen Pharmaceuticals completes its equity financing

IP Advocate collaborates with Marion Kauffman Foundation on education and policy initiatives

IP Advocate collaborates with Marion Kauffman Foundation on education and policy initiatives

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Recession impacts health: AOA survey

Recession impacts health: AOA survey

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

Can-Fite BioPharma commences preparatory work for a Phase III trial with CF101 to treat Psoriasis

MacuSight's clinical development update on its proprietary ocular sirolimus product

MacuSight's clinical development update on its proprietary ocular sirolimus product

IP Advocate founder to speak on commercialization barriers faced by university faculty inventors

IP Advocate founder to speak on commercialization barriers faced by university faculty inventors

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

FDA approves Sirion's Zirgan for treating acute herpetic keratitis

FDA approves Sirion's Zirgan for treating acute herpetic keratitis

Alcon to acquire ESBATech AG

Alcon to acquire ESBATech AG

Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution

Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution

Inspire Pharmaceuticals wins award for its denufosol tetrasodium program

Inspire Pharmaceuticals wins award for its denufosol tetrasodium program

Preliminary Phase 3 clinical study results of T-Pred released

Preliminary Phase 3 clinical study results of T-Pred released